Загрузка...
Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain
OBJECTIVE: To evaluate the budget impact and the direct costs of the introduction of subcutaneous belimumab (SC) into the Spanish National Health Service (NHS) for patients with systemic lupus erythematosus (SLE) in Spain. METHODS: This study was conducted from the Spanish NHS perspective with a tim...
Сохранить в:
| Опубликовано в: : | Clinicoecon Outcomes Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901000/ https://ncbi.nlm.nih.gov/pubmed/31824182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S218464 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|